Pricing Log in Create free account

ARAVIVE, INC (ARAV) vs GRI Bio, Inc. (GRI)

ARAVIVE, INC and GRI Bio, Inc. are both Biotechnology companies. ARAVIVE, INC and GRI Bio, Inc. are of similar size ($3.1M and $3.0M). ARAVIVE, INC has negative trailing earnings, so its P/E is not meaningful; GRI Bio, Inc. trades at 0.0×. GRI Bio, Inc. has the higher net margin (0.00% vs −569.7%) and the higher return on invested capital (0.00% vs 0.00%). Across the 13 metrics below, GRI Bio, Inc. leads on 11 and ARAVIVE, INC on 2.

Valuation

Metric ARAV GRI Biotechnology median
P/E n/m 0.02 8.50
P/S 0.43 n/m 9.71
P/B 1.78 0.24 2.13
Price to free cash flow n/m n/m 20.82
EV/EBITDA 0.05 0.86 0.64
EV/Sales (0.44) n/m 9.21
Earnings yield (1,500.00%) 5,408.03% (33.15%)
Free cash flow yield (2,072.58%) (418.56%) (25.50%)

Profitability

Metric ARAV GRI Biotechnology median
Gross margin 100.00% 0.00% 65.16%
Operating margin (847.42%) 0.00% 0.00%
Net margin (569.65%) 0.00% 0.00%
Free cash flow margin (849.92%) 0.00% 0.00%
Return on equity (475.98%) (142.02%) (56.36%)
Return on assets (144.19%) (113.27%) (48.04%)
Return on invested capital 0.00% 0.00% 0.00%

Growth

Metric ARAV GRI Biotechnology median
Revenue growth (TTM) (19.11%) — 6.02%
EPS growth (last fiscal year) (7.69%) 92.12% 30.26%
Revenue growth, 5-year CAGR (25.57%) — 9.41%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric ARAV GRI Biotechnology median
Debt to equity 0.00 0.00 0.00
Current ratio 0.98 10.30 4.72
Net debt to EBITDA 0.77 0.69 0.96

Dividend

Metric ARAV GRI Biotechnology median
Dividend yield — — 0.09%
Payout ratio — — —

Size

Metric ARAV GRI Biotechnology median
Market cap 2.95m 3.06m 135.18m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack